Pharmaceutical formulation containing gelling agent
Granted 22 Nov 2016 · 7 office actions
Assignee: Purdue Pharma
Law firm: Law firm · Log in to unlock
Attorney: Attorney · Log in to unlock
Inventors: Curtis Wright, Benjamin Oshlack, Christopher Breder · Examiner: Robert A Wax · AU 1615 · TC 1600
Life of the application
13 dated eventsAbstract
Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.
Claims as granted
18 claimsLog in to read the claims of this application.
Log in to unlockClassifications
24 codes- A61K47/34
- A61K31/137
- A61K9/48
- A61K9/00
- A61K31/48
- A61K47/26
- A61K31/439
- A61K9/06
- A61K47/10
- A61K9/50
- A61K47/36
- A61K47/32
- A61K9/16
- A61K9/08
- A61K9/28
- A61K9/20
- A61K47/08
- A61K31/4458
- A61K47/12
- A61K45/06
- A61K31/192
- A61K47/38
- A61K31/485
- A61K31/167
Claim changes
SoonSee which claims were amended, added or cancelled during examination, with every added and removed word marked.
The published claims of this application are not paired with the granted ones in what we hold.
File wrapper
See the full prosecution history — every USPTO and applicant action on this file, in order.
Log in to unlockDocuments
Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.
Log in to unlockChain of title
No assignments have been recorded for this application yet.